Artykuły w czasopismach na temat „Cer-001”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 45 najlepszych artykułów w czasopismach naukowych na temat „Cer-001”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Zheng, Kang He, Fleur M. van der Valk, Loek P. Smits, Mara Sandberg, Jean-Louis Dasseux, Rudi Baron, Ronald Barbaras i in. "HDL mimetic CER-001 targets atherosclerotic plaques in patients". Atherosclerosis 251 (sierpień 2016): 381–88. http://dx.doi.org/10.1016/j.atherosclerosis.2016.05.038.
Pełny tekst źródłaOssoli, A., A. Strazzella, S. Simonelli, D. Rottoli, M. Abbate, C. M. Zoja, J. L. Dasseux i L. Calabresi. "Remodeling And Catabolism Of Cer-001 In Absence Of Lcat Enzyme". Atherosclerosis 287 (sierpień 2019): e107. http://dx.doi.org/10.1016/j.atherosclerosis.2019.06.312.
Pełny tekst źródłaKeyserling, Constance H., Ronald Barbaras, Renee Benghozi i Jean-Louis Dasseux. "Development of CER-001: Preclinical Dose Selection Through to Phase I Clinical Findings". Clinical Drug Investigation 37, nr 5 (17.02.2017): 483–91. http://dx.doi.org/10.1007/s40261-017-0506-3.
Pełny tekst źródłaNicholls, Stephen J., Jordan Andrews, John J. P. Kastelein, Bela Merkely, Steven E. Nissen, Kausik K. Ray, Gregory G. Schwartz i in. "Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial". JAMA Cardiology 3, nr 9 (1.09.2018): 815. http://dx.doi.org/10.1001/jamacardio.2018.2121.
Pełny tekst źródłaLi, Chen, Pan Pan Wu i Kun Zhang. "Preparaitve Separation and Purification of Cordycepin from Cultured Cordyceps militaris Using Cation Exchange Resin". Advanced Materials Research 550-553 (lipiec 2012): 1773–78. http://dx.doi.org/10.4028/www.scientific.net/amr.550-553.1773.
Pełny tekst źródłaFlores-Peña, Yolanda, María Eugenia Pérez-Campa, Hermelinda Ávila-Alpirez, Juana Mercedes Gutiérrez-Valverde i Gustavo Gutiérrez-Sánchez. "Depressive symptoms, maternal feeding styles, and preschool child’s body weight". Salud mental 44, nr 6 (2.12.2021): 261–66. http://dx.doi.org/10.17711/sm.0185-3325.2021.034.
Pełny tekst źródłaFaguer, Stanislas, Magali Colombat, Dominique Chauveau, Pauline Bernadet-Monrozies, Audrey Beq, Audrey Delas, Vincent Soler i in. "Administration of the High-Density Lipoprotein Mimetic CER-001 for Inherited Lecithin–Cholesterol Acyltransferase Deficiency". Annals of Internal Medicine 174, nr 7 (lipiec 2021): 1022–25. http://dx.doi.org/10.7326/l20-1300.
Pełny tekst źródłaNicholls, Stephen J., Jordan Andrews, John Jp Kastelein, Bela Merkely, Steven E. Nissen, Kausik Ray, Gregory G. Schwartz i in. "CARAT: will infusing a pre-beta high-density lipoprotein mimetic (CER-001) regress coronary atherosclerosis?" Atherosclerosis 263 (sierpień 2017): e10. http://dx.doi.org/10.1016/j.atherosclerosis.2017.06.060.
Pełny tekst źródłaOssoli, A., A. Strazzella, D. Rottoli, C. Zanchi, M. Locatelli, C. Zoja, S. Simonelli i in. "CER-001 ameliorates lipid profile and kidney disease in a mouse model of familial LCAT deficiency". Atherosclerosis 331 (sierpień 2021): e39. http://dx.doi.org/10.1016/j.atherosclerosis.2021.06.112.
Pełny tekst źródłaFaguer, S., M. Colombat, D. Chauveau, P. Bernadet, A. Delas, V. Soler, I. Labadens, A. Huart i J. Schanstra. "Place du mimétique HDL CER-001 dans la glomérulopathie secondaire aux déficits en lécithine-cholestérol acyltransférase (LCAT)". Néphrologie & Thérapeutique 17, nr 5 (wrzesień 2021): 317–18. http://dx.doi.org/10.1016/j.nephro.2021.07.182.
Pełny tekst źródłaPavanello, Chiara, Marta Turri, Arianna Strazzella, Patrizia Tulissi, Stefano Pizzolitto, Giovanna De Maglio, Riccardo Nappi, Laura Calabresi i Giuliano Boscutti. "The HDL mimetic CER‐001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiency". Journal of Internal Medicine 291, nr 3 (11.11.2021): 364–70. http://dx.doi.org/10.1111/joim.13404.
Pełny tekst źródłaZheng, Kang H., Yannick Kaiser, Casper C. van Olden, Raul D. Santos, Jean-Louis Dasseux, Jacques Genest, Daniel Gaudet i in. "No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels". Atherosclerosis 311 (październik 2020): 13–19. http://dx.doi.org/10.1016/j.atherosclerosis.2020.08.004.
Pełny tekst źródłaTardy, Claudine, Marine Goffinet, Nadia Boubekeur, Guy Cholez, Rose Ackermann, Gavin Sy, Constance Keyserling i in. "HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation". PLOS ONE 10, nr 9 (3.09.2015): e0137584. http://dx.doi.org/10.1371/journal.pone.0137584.
Pełny tekst źródłaLawrence, Caroline, Erica E. Fortune, Heather Badt, Kara Doughtie, Madyson L. Popalis i Melissa F. Miller. "Abstract P4-05-01: Cancer-Related Distress and Unmet Needs Among Triple Negative Breast Cancer Patients: Findings from the Cancer Experience Registry". Cancer Research 83, nr 5_Supplement (1.03.2023): P4–05–01—P4–05–01. http://dx.doi.org/10.1158/1538-7445.sabcs22-p4-05-01.
Pełny tekst źródłaAndrews, Jordan, Alex Janssan, Tracy Nguyen, Anthony D. Pisaniello, Daniel J. Scherer, John J. P. Kastelein, Bela Merkely i in. "Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study". Cardiovascular Diagnosis and Therapy 7, nr 1 (luty 2017): 45–51. http://dx.doi.org/10.21037/cdt.2017.01.01.
Pełny tekst źródłaKataoka, Yu, Jordan Andrews, MyNgan Duong, Tracy Nguyen, Nisha Schwarz, Jessica Fendler, Rishi Puri i in. "Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden". Cardiovascular Diagnosis and Therapy 7, nr 3 (czerwiec 2017): 252–63. http://dx.doi.org/10.21037/cdt.2017.02.01.
Pełny tekst źródłaHovingh, G. K., E. S. Stroes, D. Gaudet, C. Stefanutti, H. Soran, S. Kwok, J. de Graaf i in. "Effects of CER-001 on carotid atherosclerosis by 3tmri in homozygous familial hypercholesterolemia (HoFH): The modifying orphan disease evaluation (mode) study". Atherosclerosis 235, nr 2 (sierpień 2014): e13-e14. http://dx.doi.org/10.1016/j.atherosclerosis.2014.05.008.
Pełny tekst źródłaTardif, J. C., C. M. Ballantyne, P. Barter, J. L. Dasseux, Z. A. Fayad, M. C. Guertin, J. J. P. Kastelein i in. "Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial". European Heart Journal 35, nr 46 (29.04.2014): 3277–86. http://dx.doi.org/10.1093/eurheartj/ehu171.
Pełny tekst źródłaTardy, Claudine, Marine Goffinet, Nadia Boubekeur, Rose Ackermann, Gavin Sy, Alice Bluteau, Guy Cholez i in. "CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice". Atherosclerosis 232, nr 1 (styczeń 2014): 110–18. http://dx.doi.org/10.1016/j.atherosclerosis.2013.10.018.
Pełny tekst źródłaFranzin, Rossana, Alessandra Stasi, Marco Fiorentino, Irene Scalera, Monica Campioni, Maria Teresa Cimmarusti, Giuseppe Castellano i in. "CER-001, a Recombinant HDL, Modulates Ischemia/Reperfusion Injury (IRI) in Hypothermic (HMP) and Normothermic Perfusion (NMP) Solutions Through pAKT/eNOS Activation". Journal of the American Society of Nephrology 34, nr 11S (listopad 2023): 23. http://dx.doi.org/10.1681/asn.20233411s123c.
Pełny tekst źródłaKootte, Ruud S., Loek P. Smits, Fleur M. van der Valk, Jean-Louis Dasseux, Constance H. Keyserling, Ronald Barbaras, John F. Paolini i in. "Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA". Journal of Lipid Research 56, nr 3 (5.01.2015): 703–12. http://dx.doi.org/10.1194/jlr.m055665.
Pełny tekst źródłaKootte, R. S., L. P. Smits, F. M. van der Valk, J. L. Dasseux, C. Keyserling, R. Barbaras, J. Paolini i in. "Recombinant human apolipoprotein-a-i prebeta-HDL (cer-001) promotes reverse cholesterol transport and reduces carotid wall thickness in patients with genetically-determined low HDL". Atherosclerosis 235, nr 2 (sierpień 2014): e14. http://dx.doi.org/10.1016/j.atherosclerosis.2014.05.009.
Pełny tekst źródłaHovingh, G. Kees, Loek P. Smits, Claudia Stefanutti, Handrean Soran, See Kwok, Jacqueline de Graaf, Daniel Gaudet i in. "The effect of an apolipoprotein A-I–containing high-density lipoprotein–mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia". American Heart Journal 169, nr 5 (maj 2015): 736–42. http://dx.doi.org/10.1016/j.ahj.2015.01.008.
Pełny tekst źródłaStroes, E., R. Benghozi, J. L. Dasseux, J. Genest, H. Ginsberg, C. Keyserling, E. Leitersdorf, P. Raggi i A. von Eckardstein. "A phase III multicentre, double-blind, placebo-controlled study (TANGO) to evaluate CER-001 on carotid atherosclerosis (vessel wall area) in patients with familial primary hypoalphalipoproteinaemia". Atherosclerosis 252 (wrzesień 2016): e111-e112. http://dx.doi.org/10.1016/j.atherosclerosis.2016.07.609.
Pełny tekst źródłaLe, Loan, Daniel J. Schwartz, Risa Nakase-Richardson, Emily J. Almeida, William Anderson, Kevin Patel, Benjamin Sudolcan i Sagarika Nallu. "0556 Simultaneous comparison of unedited and manually edited HSAT with level 1 PSG in persons with hospitalized TBI". SLEEP 46, Supplement_1 (1.05.2023): A245. http://dx.doi.org/10.1093/sleep/zsad077.0556.
Pełny tekst źródłaKnapik, Katarzyna, Karolina Sieroń, Ewa Wojtyna, Grzegorz Onik, Ewa Romuk, Ewa Birkner, Agata Stanek, Aleksandra Kawczyk-Krupka, Ryszard Plinta i Aleksander Sieroń. "Precompetitional Weight Reduction Modifies Prooxidative-Antioxidative Status in Judokas". Oxidative Medicine and Cellular Longevity 2019 (22.07.2019): 1–9. http://dx.doi.org/10.1155/2019/2164698.
Pełny tekst źródłaCordeiro Juliani, Fabiana, Viviane Zorzanelli Rocha, Ana Paula Marte Chacra i Raul Dias dos Santos. "HIPOALFALIPOPROTEINEMIAS: DIAGNÓSTICO DIFERENCIAL, APRESENTAÇÃO CLÍNICA E DESAFIO TERAPÊUTICO". Revista da Sociedade de Cardiologia do Estado de São Paulo 31, nr 1 (1.04.2021): 23–31. http://dx.doi.org/10.29381/0103-8559/2021310123-31.
Pełny tekst źródłaDoughtie, Kara, Erica E. Fortune, Heather Badt, Caroline Lawrence, Madyson L. Popalis i Melissa F. Miller. "Abstract P6-05-29: Experience of Financial Toxicity and Distress Among Individuals Diagnosed with Triple Negative Breast Cancer: Findings from the Cancer Experience Registry". Cancer Research 83, nr 5_Supplement (1.03.2023): P6–05–29—P6–05–29. http://dx.doi.org/10.1158/1538-7445.sabcs22-p6-05-29.
Pełny tekst źródłaKuandykova, Elvira, Bakhitzhan Kuandykov, Sabit Daubassov, Manshuk Beysenbaeva, Duman Kussainov i Bayan Ashyralieva. "Legal basis of international agricultural organizations". RIVISTA DI STUDI SULLA SOSTENIBILITA' 13, nr 1 (listopad 2023): 217–31. http://dx.doi.org/10.3280/riss2023-001-s1014.
Pełny tekst źródłaStrobel, Sabine, i Thomas Schleid. "Quaternäre Strontium-Kupfer(I)-Lanthanoid(III)-Selenide mit Cer und Praseodym: SrCuCeSe3 und SrCuPrSe3, ein ungleiches Geschwisterpaar / Quaternary Strontium Copper(I) Lanthanoid(III) Selenides with Cerium and Praseodymium: SrCuCeSe3 and SrCuPrSe3, Unequal Brother and Sister". Zeitschrift für Naturforschung B 59, nr 9 (1.09.2004): 985–91. http://dx.doi.org/10.1515/znb-2004-0907.
Pełny tekst źródłaGoffinet, Marine, Claudine Tardy, Alice Bluteau, Nadia Boubekeur, Rudi Baron, Constance Keyserling, Ronald Barbaras, Narendra Lalwani i Jean-Louis Dasseux. "Abstract 18667: Anti-atherosclerotic Effect of CER-001, an Engineered HDL-mimetic, in the High-fat Diet-fed LDLr Knockout Mice". Circulation 126, suppl_21 (20.11.2012). http://dx.doi.org/10.1161/circ.126.suppl_21.a18667.
Pełny tekst źródłaStasi, Alessandra, Marco Fiorentino, Rossana Franzin, Francesco Staffieri, Sabrina Carparelli, Rosa Losapio, Alberto Crovace i in. "Beneficial effects of recombinant CER-001 high-density lipoprotein infusion in sepsis: results from a bench to bedside translational research project". BMC Medicine 21, nr 1 (2.11.2023). http://dx.doi.org/10.1186/s12916-023-03057-5.
Pełny tekst źródłaBarbaras, Ronald. "Non-clinical development of CER-001". Frontiers in Pharmacology 6 (6.10.2015). http://dx.doi.org/10.3389/fphar.2015.00220.
Pełny tekst źródłaStasi, Alessandra, Rossana Franzin, Marco Fiorentino, Francesco Staffieri, Rosa Losapio, Maria Teresa Cimmarusti, Alberto Crovace i in. "#4015 RECOMBINANT HIGH-DENSITY LIPOPROTEIN MODULATES INFLAMMATORY RESPONSE AND RENAL DYSFUNCTION IN A SWINE MODEL OF SEPSIS-INDUCED ACUTE KIDNEY INJURY". Nephrology Dialysis Transplantation 38, Supplement_1 (czerwiec 2023). http://dx.doi.org/10.1093/ndt/gfad063a_4015.
Pełny tekst źródłaKalayci, Arzu, C. Michael Gibson, Paul M. Ridker, Samuel D. Wright, Bronwyn A. Kingwell, Serge Korjian, Gerald Chi i in. "ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future". Current Atherosclerosis Reports, 7.05.2022. http://dx.doi.org/10.1007/s11883-022-01025-7.
Pełny tekst źródłaFranzin, Rossana, Alessandra Stasi, Marco Fiorentino, Fabio Sallustio, Ronald Barbaras, Connie Peyrottes, Cyrille Tupin, Giuseppe Castellano, Paola Pontrelli i Loreto Gesualdo. "MO287: A Recombinant BIO-HDL (CER-001) Can Prevent SARS-COV2-Induced Renal Dysfunction by Restoring SR-BI Signalling". Nephrology Dialysis Transplantation 37, Supplement_3 (maj 2022). http://dx.doi.org/10.1093/ndt/gfac067.086.
Pełny tekst źródłaKataoka, Yu, Jordan Andrews, MyNgan Duong, Tracy Nguyen, Nisha Schwarz, Jessica Fendler, Rishi Puri i in. "Abstract 12156: Greater Regression of Coronary Atherosclerosis With the Pre-Beta High-Density Lipoprotein Mimetic CER-001 in Patients With More Extensive Plaque Burden". Circulation 132, suppl_3 (10.11.2015). http://dx.doi.org/10.1161/circ.132.suppl_3.12156.
Pełny tekst źródłaFaguer, Stanislas, Arnaud Del Bello, Chloé Danet, Yves Renaudineau, Jacques Izopet i Nassim Kamar. "Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study". Frontiers in Pharmacology 13 (26.09.2022). http://dx.doi.org/10.3389/fphar.2022.936659.
Pełny tekst źródłaWoodall, J. M. "Contactless Electromodulation Characterization of Compound Semiconductor Surfaces and Device Structures". MRS Proceedings 324 (1993). http://dx.doi.org/10.1557/proc-324-141.
Pełny tekst źródłaOssoli, Alice, Arianna Strazzella, Daniela Rottoli, Cristina Zanchi, Monica Locatelli, Carlamaria Zoja, Sara Simonelli i in. "CER-001 ameliorates lipid profile and kidney disease in a mouse model of Familial LCAT Deficiency". Metabolism, grudzień 2020, 154464. http://dx.doi.org/10.1016/j.metabol.2020.154464.
Pełny tekst źródłaRomero, Natividad Calvo, Jesús Domínguez Delgado-Palacios, Marta Calvo Arevalo, Isabel Pérez-Flores, Beatriz Rodríguez Cubillo, María Ángeles Moreno de la Higuera Díaz, María Muñiz Rincón, Arianne Aiffil Meneses, Rómulo Katsu Loayza López i Ana Sanchez Fructuoso. "#5146 KINETIC ESTIMATION OF GFR AND URINARY CREATININE EXCRETION RATE AS PREDICTORS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANTS FROM DECEASED DONORS". Nephrology Dialysis Transplantation 38, Supplement_1 (czerwiec 2023). http://dx.doi.org/10.1093/ndt/gfad063c_5146.
Pełny tekst źródłaQing, Shuiwang, Lei Gu, Tingting Du, Xiaolan Yin, Ke-jia Zhang i Huo-jun Zhang. "A Predictive Model to Evaluate Pathologic Complete Response in Rectal Adenocarcinoma". Technology in Cancer Research & Treatment 22 (styczeń 2023). http://dx.doi.org/10.1177/15330338231202893.
Pełny tekst źródłaGoto, Ken, Tomo Ueno i Yoshinao Kumagai. "Heterostructure formation of group-III sesquioxides via cation-exchange reactions with metal chloride gases". AIP Advances 13, nr 8 (1.08.2023). http://dx.doi.org/10.1063/5.0143736.
Pełny tekst źródłaSrivastava, Rai Ajit K., Angelo B. Cefalu, Davide Noto, Donata Panno, Antonella Giammanco Giammanco i Maurizio R. Averna. "Abstract 9805: Lack of Correlation Between HDL Level and Fecal Cholesterol in Multiple Mouse Models Suggests Importance of HDL Functionality in Atherosclerosis Attenuation". Circulation 132, suppl_3 (10.11.2015). http://dx.doi.org/10.1161/circ.132.suppl_3.9805.
Pełny tekst źródłaDoebele, Robert C., Laura Perez, Huong Trinh, Michael Martinec, Reynaldo Martina, Todd Riehl, Matthew G. Krebs, Neal J. Meropol, William B. Wong i Gracy Crane. "Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data in ROS1+ NSCLC". Journal of Comparative Effectiveness Research, 24.08.2021. http://dx.doi.org/10.2217/cer-2021-0131.
Pełny tekst źródła